Roche invests $550m to make Indianapolis a CGM manufacturing hub

Roche has announced that it plans to invest up to $550m to expand its continuous glucose monitoring (CGM) site in the US. The company plans to invest in its Diagnostics site in Indianapolis in a project to make the site a major hub for manufacturing its CGM systems.

Roche says that its Indianapolis campus houses key operations, including R&D, labs, manufacturing, distribution, IT and administrative functions. It currently produces approximately 5.2bn Accu-Chek diabetes test strips annually.

The company expects the expansion to generate hundreds of highly skilled manufacturing jobs and thousands of construction jobs.

To find out more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).